Read More: https://www.benzinga.com/insights/news/25/01/42757376/heres-how-much-you-would-have-made-owning-thermo-fisher-scientific-stock-in-the-last-20-years?utm_source=TechInvestorNews&utm_campaign=partner_feed&utm_medium=partner_feed&utm_content=site
BioMarin Pharmaceutical Inc. experienced a notable decrease in short interest in December, with short interest recorded as of December 15th.
Sangamo Therapeutics’ premarket value dropped by 50% due to a setback from Pfizer.
Click the link to read more of the story. Thefly.com offers up-to-date financial news and is recognized for its market intelligence. Their live news feed provides constant updates for individuals.
Read More: https://www.tipranks.com/news/company-announcements/radiopharm-partners-with-lantheus-to-advance-oncology-treatments?utm_source=alphanewsstream.com&utm_medium=referral
Radiopharm collaborates with Lantheus to enhance cancer therapy options. Read More »
If you invested in 2024, you likely benefited greatly if you owned large cap tech stocks, mutual funds, or certain other assets.
Investors should be happy about their significant gains in 2024. Read More »
Investors likely found 2024 to be very favorable, particularly if they owned certain types of assets such as big tech stocks or mutual funds.
Investors should be happy about the significant gains they made in 2024. Read More »
Crescita Therapeutics Inc. Director Jose Darocha bought 86,000 shares of the company’s stock on December 27th. The purchase was made at an undisclosed price.
Stay updated with the latests analysis and insights fromm etfsector.com
